Announcement on Voluntary Disclosure of Receipt by the Joint-stock Company of the Phase I Clinical Study Report for ZG-002 Tablets
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment